All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F14%3A00061228" target="_blank" >RIV/00159816:_____/14:00061228 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1111/iep.12094" target="_blank" >http://dx.doi.org/10.1111/iep.12094</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/iep.12094" target="_blank" >10.1111/iep.12094</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model

  • Original language description

    Oncological research indicated a possible role of statins in the risk reduction of certain malignancies. The purpose of this experiment was to examine the chemopreventive effects of pravastatin alone and in combination with pineal hormone melatonin in the model of N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats. Pravastatin was administered dietary (100 mg/kg) and melatonin in a water solution (20 mýg/ml). Chemoprevention began 7 days prior to carcinogen administration and subsequently continued 15 weeks until to autopsy. At autopsy, mammary tumours were removed and prepared for histopathological and immunohistochemical analysis. Parameters of experimental carcinogenesis, mechanism of action (biomarkers of apoptosis, angiogenesis and proliferation) and side effects after long-term treatment in animals were assessed. Pravastatin alone suppressed tumour frequency by 20.5% and average tumour volume by 15% compared with controls. Combined administration of the drugs de

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: St. Anne´s University Hospital Brno - International Clinical Research Center (FNUSA-ICRC)</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    International Journal of Experimental Pathology

  • ISSN

    0959-9673

  • e-ISSN

  • Volume of the periodical

    96

  • Issue of the periodical within the volume

    6

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    10

  • Pages from-to

    401-410

  • UT code for WoS article

    000346972300004

  • EID of the result in the Scopus database